Cargando…
MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN
HER2-overexpressing breast cancers are characterized by frequent distant metastasis and often develop resistance after short-term effective treatment with the monoclonal antibody drug, trastuzumab. Here, we found that the oncogenic miRNA, miR-221, inhibited apoptosis, induced trastuzumab resistance...
Autores principales: | Ye, Xingming, Bai, Wendong, Zhu, Huayu, Zhang, Xiao, Chen, Ying, Wang, Lei, Yang, Angang, Zhao, Jing, Jia, Lintao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163864/ https://www.ncbi.nlm.nih.gov/pubmed/24286315 http://dx.doi.org/10.5483/BMBRep.2014.47.5.165 |
Ejemplares similares
-
Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
por: Ye, Xing-Ming, et al.
Publicado: (2014) -
MiR-221/222 Ameliorates Deoxynivalenol-Induced Apoptosis and Proliferation Inhibition in Intestinal Epithelial Cells by Targeting PTEN
por: Hou, Lianjie, et al.
Publicado: (2021) -
miR-21, miR-221, and miR-222 upregulation in lung cancer promotes metastasis by reducing oxidative stress and apoptosis
por: Tepebaşı, Muhammet Yusuf, et al.
Publicado: (2023) -
Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells
por: Noyan, Senem, et al.
Publicado: (2019) -
Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling
por: Di Paolo, Daniela, et al.
Publicado: (2021)